Vectormune FP-MG

This page contains information on Vectormune FP-MG for veterinary use.
The information provided typically includes the following:
  • Vectormune FP-MG Indications
  • Warnings and cautions for Vectormune FP-MG
  • Direction and dosage information for Vectormune FP-MG

Vectormune FP-MG

This treatment applies to the following species:
Manufacturer: Ceva Biomune

FOWL POX - MYCOPLASMA GALLISEPTICUM VACCINE

Live Fowl Pox Vector

Description

This vaccine contains a genetically engineered live poxvirus for the vaccination of chickens and turkeys as an aid in the prevention of fowl pox and Mycoplasma gallisepticum. The fowl pox vaccine has been genetically engineered to contain and express key protective Mycoplasma gallisepticum antigens.

Vectormune FP-MG Indications

Administer by wing web method to healthy, susceptible chickens at least eight weeks old. Administer by wing web method to healthy, susceptible turkeys at least four weeks old. Chickens and turkeys receiving this vaccine must not have been previously vaccinated with a fowl pox vaccine.

Dosage and Administration

Remove the seal and stopper from the vaccine vial and diluent vial. Pour the entire contents of the diluent vial into the vaccine vial, insert the stopper, and shake well. The vaccine is ready for use and should be used within one hour. Hold each individual bird and spread the wing with the underside facing up. Dip the two-pronged wing web applicator into the vaccine so that the grooves fill with liquid and deliver 0.01 ml per bird. Insert the double-pronged applicator into the web portion of the wing avoiding blood vessels, muscle, and bone.

Seven to ten days after vaccination, observe several chickens for evidence of "takes" that includes swelling and/or scab formation at the injection site. Turkeys should be examined for evidence of “takes” at ten to fourteen days after vaccination.

Birds receiving this vaccine must not have been previously vaccinated with a fowl pox vaccine.

Vectormune FP-MG Caution

Store vaccine at 35-45°F (2-7°C). Do not vaccinate within 21 days of slaughter. Use entire contents immediately after rehydrating. Burn containers and all unused contents. Contains gentamicin and amphotericin B as preservatives. Federal regulations prohibit repackaging or sale of the contents of this package in fractional units. Do not accept if seal is broken. All birds on a farm should be vaccinated at one time. Vaccination should be completed at least 4 weeks prior to the start of lay. For veterinary use only.

Patent Pending

BIOMUNE CO., Lenexa, Kansas 66215 USA

Phone (913) 894-0230

U.S. Vet Lic. No. 368

10 x 1000 DOSES

1249

NAC No.: 11290521

CEVA BIOMUNE
8906 ROSEHILL ROAD, LENEXA, KS, 66215
Telephone:   913-894-0230
Fax:   913-894-0236
Website:   www.ceva-us.com
Every effort has been made to ensure the accuracy of the Vectormune FP-MG information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2014 North American Compendiums. Updated: 2014-09-05

(web2)